Global Bioprinting Software Market Growth (Status and Outlook) 2025-2031

The global Bioprinting Software market size is predicted to grow from US$ 95.2 million in 2025 to US$ 208 million in 2031; it is expected to grow at a CAGR of 13.9% from 2025 to 2031.

Bioprinting software is a software system specifically used to control and manage the bioprinting process. It integrates multidisciplinary knowledge such as biology, computer science, and materials science. It can convert biomedical data into actionable printing instructions, accurately control the operation of bioprinters, and realize three-dimensional printing of biological tissues and organs.

United States market for Bioprinting Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Bioprinting Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Bioprinting Software is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Bioprinting Software players cover ‌Organovo, CELLINK, ‌EnvisionTEC, Materialise, BioBots, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Bioprinting Software Industry Forecast” looks at past sales and reviews total world Bioprinting Software sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioprinting Software sales for 2025 through 2031. With Bioprinting Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioprinting Software industry.

This Insight Report provides a comprehensive analysis of the global Bioprinting Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Bioprinting Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioprinting Software market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioprinting Software and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioprinting Software.

This report presents a comprehensive overview, market shares, and growth opportunities of Bioprinting Software market by product type, application, key players and key regions and countries.

Segmentation by Type:
Cloud-based
On-premises

Segmentation by Application:
Tissue Regeneration
Pharmacokinetic Studies
Tumor Studies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
‌Organovo
CELLINK
‌EnvisionTEC
Materialise
BioBots
Allevi
REGENHU
3D Systems
Black Drop
Poietis
Regenovo Biotechnology

Please note: The report will take approximately 2 business days to prepare and deliver.